If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,644.00    22.00 (0.84%)
Bid:
2,639.00
Ask:
2,641.00
Spread: 2.00 (0.076%)
Market Cap: £23.49b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Second Interim Dividend

Today 17:06

RNS Number : 0444L
Experian plc
03 July 2026
 

Experian plc

 

 

Second interim dividend - exchange rate and Irish dividend withholding tax

 

 

3 July 2026 - Experian plc, the global data and technology company (the "Company"), hereby notifies the market that, further to the announcement on 20 May 2026 of a second interim dividend of 48.00 US cents per ordinary share payable on 24 July 2026 to shareholders on the register of members at the close of business on 26 June 2026, the exchange rate to be used to convert the dividend payment from US dollars to sterling pounds, for those shareholders who did not elect by 26 June 2026 to receive payment in US dollars, will be £1 = $1.33576. Accordingly, the sterling amount of dividend payable on 24 July 2026 to such shareholders will be approximately 35.9345 pence per share.

 

Shareholders who did not elect to receive UK sourced dividends through the income access share arrangements are reminded that, as previously advised, their dividends will be subject to Irish dividend withholding tax unless the Company's Registrars are in possession of a valid exemption form. As previously advised, the final date for submission of elections to receive UK sourced dividends via the income access share arrangements was 26 June 2026. In the absence of any such elections, previous elections or deemed elections will remain in force.

 

Contact:

 

Experian

Claire Murphy

Deputy Company Secretary

+353 (0) 87 118 4397

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and platforms. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland.

 

Learn more at experianplc.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVQXLFBQDLBBBZ
Date   Source Headline
19th Feb 20255:17 pmRNSTransaction in Own Shares
18th Feb 20255:45 pmRNSTransaction in Own Shares
12th Feb 20257:00 amRNSDirectorate Change
10th Feb 20254:08 pmRNSDirector/PDMR Shareholding
31st Jan 202511:41 amRNSTotal Voting Rights
24th Jan 202510:25 amRNSOutcome of audit tender process
17th Jan 20255:14 pmRNSFirst interim dividend
16th Jan 20255:14 pmRNSBond Issue
15th Jan 20257:00 amRNSExperian Q3 FY25 trading update
31st Dec 202410:16 amRNSTotal Voting Rights
23rd Dec 20241:39 pmRNSShare repurchase programme
20th Dec 20249:00 amRNSElections for first interim dividend
12th Dec 20249:25 amRNSDirector Declaration
29th Nov 20243:56 pmRNSTotal Voting Rights
13th Nov 20247:00 amRNSHalf-year Report
5th Nov 20241:51 pmRNSTotal Voting Rights - Amendment
31st Oct 202412:19 pmRNSTotal Voting Rights
4th Oct 202412:44 pmRNSExperian to acquire Clearsale in Brazil
30th Sep 202412:30 pmRNSTotal Voting Rights
30th Sep 20248:29 amRNSExperian Completes Acquisition of Ilion
16th Sep 202412:10 pmRNSBlock listing Interim Review
4th Sep 20243:30 pmRNSBond Issue
30th Aug 20243:15 pmRNSTotal Voting Rights
7th Aug 20249:34 amRNSDirector/PDMR Shareholding
31st Jul 202410:59 amRNSTotal Voting Rights
23rd Jul 202410:13 amRNSDirector/PDMR Shareholding
17th Jul 202411:15 amRNSResult of AGM
16th Jul 20247:00 amRNSDirectorate Change
16th Jul 20247:00 amRNSTrading update, first quarter
28th Jun 20245:35 pmRNSSecond interim dividend
28th Jun 20243:10 pmRNSTotal Voting Rights
27th Jun 20249:15 amRNSDirector/PDMR Shareholding
17th Jun 20244:00 pmRNSDirector/PDMR Shareholding
12th Jun 202411:30 amRNSDirector/PDMR Shareholding
7th Jun 20241:34 pmRNSAnnual Financial Report
31st May 20244:12 pmRNSTotal Voting Rights
31st May 20249:36 amRNSElections for Second Interim Dividend
23rd May 20245:30 pmRNSHolding(s) in Company
15th May 20241:30 pmRNSShare repurchases
15th May 20247:00 amRNSFull-year financial report
30th Apr 20245:24 pmRNSTransaction in Own Shares
30th Apr 202411:22 amRNSTotal Voting Rights
29th Apr 20245:52 pmRNSTransaction in Own Shares
26th Apr 20245:19 pmRNSTransaction in Own Shares
25th Apr 20245:16 pmRNSTransaction in Own Shares
24th Apr 20245:14 pmRNSTransaction in Own Shares
23rd Apr 20245:28 pmRNSTransaction in Own Shares
22nd Apr 20245:34 pmRNSTransaction in Own Shares
19th Apr 20245:42 pmRNSTransaction in Own Shares
18th Apr 20245:41 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.